Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
relapsed AML
Description:
Acute myeloid leukemia (AML) that has returned after remission, considered in studies of salvage treatment and transplantation.
Primary topic:
Acute Myeloid Leukemia Research (73%)
Related topics:
Acute Myeloid Leukemia Research (73%),
Hematopoietic Stem Cell Transplantation (8%)
OpenAlex ID:
keywords/relapsed-aml
Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells
2018
·
Courtney L. Jones
, Brett M. Stevens
, et al.
·
Cancer Cell
·
633
PDF
Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia
2015
·
C. Michel Zwaan
, Edward A. Kolb
, et al.
·
Journal of Clinical Oncology
·
406
Phase 2 study of azacytidine plus sorafenib in patients with acute myeloid leukemia and FLT-3 internal tandem duplication mutation
2013
·
Farhad Ravandi
, Mona Lisa Alattar
, et al.
·
Blood
·
384
Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells
2020
·
Brett M. Stevens
, Courtney L. Jones
, et al.
·
Nature Cancer
·
348
The distribution of T‐cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia
2018
·
Patrick Williams
, Sreyashi Basu
, et al.
·
Cancer
·
341
Targeting of the CD33-calicheamicin immunoconjugate Mylotarg (CMA-676) in acute myeloid leukemia: in vivo and in vitro saturation and internalization by leukemic and normal myeloid cells
2001
·
Vincent H. J. van der Velden
, Jeroen G. te Marvelde
, et al.
·
Blood
·
341
High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa group
2006
·
A-L Taksin
, O Legrand
, et al.
·
Leukemia
·
300
Chemotherapy Induces Senescence-Like Resilient Cells Capable of Initiating AML Recurrence
2021
·
Cihangir Duy
, Meng Li
, et al.
·
Cancer Discovery
·
283
Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia
2016
·
Stefanie Göllner
, Thomas Oellerich
, et al.
·
Nature Medicine
·
272
Phase III Randomized Multicenter Study of a Humanized Anti-CD33 Monoclonal Antibody, Lintuzumab, in Combination With Chemotherapy, Versus Chemotherapy Alone in Patients With Refractory or First-Relapsed Acute Myeloid Leukemia
2005
·
Eric J. Feldman
, Joseph Brandwein
, et al.
·
Journal of Clinical Oncology
·
256
PDF
C-Type Lectin-Like Molecule-1
2004
·
Alexander B. H. Bakker
, Sonja van den Oudenrijn
, et al.
·
Cancer Research
·
256
FLT3-mutant allelic burden and clinical status are predictive of response to FLT3 inhibitors in AML
2009
·
Keith W. Pratz
, Takashi Sato
, et al.
·
Blood
·
249
FLT3 Mutations: Biology and Treatment
2006
·
Donald Small
·
Hematology
·
249
Targeting of acute myeloid leukaemia by cytokine‐induced killer cells redirected with a novel CD 123‐specific chimeric antigen receptor
2013
·
Sarah Tettamanti
, Virna Marin
, et al.
·
British Journal of Haematology
·
217
CD33 expression and P-glycoprotein–mediated drug efflux inversely correlate and predict clinical outcome in patients with acute myeloid leukemia treated with gemtuzumab ozogamicin monotherapy
2007
·
Roland B. Walter
, Ted A. Gooley
, et al.
·
Blood
·
201
PDF
Multidrug-resistance phenotype and clinical responses to gemtuzumab ozogamicin
2001
·
Michael L. Linenberger
, Tom Hong
, et al.
·
Blood
·
201
Venetoclax for AML: changing the treatment paradigm
2019
·
Daniel A. Pollyea
, Maria Amaya
, et al.
·
Blood Advances
·
191
PDF
Acute myeloid leukemia management and research in 2025
2024
·
Hagop M. Kantarjian
, Courtney D. DiNardo
, et al.
·
CA A Cancer Journal for Clinicians
·
188
PDF
Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Société Française de Greffe de Moelle (SFGM)
2000
·
M Michallet
, X Thomas
, et al.
·
Bone Marrow Transplantation
·
161
Pharmacodynamics of cytarabine alone and in combination with 7-hydroxystaurosporine (UCN-01) in AML blasts in vitro and during a clinical trial
2005
·
D. Sampath
, Jorge Cortes
, et al.
·
Blood
·
160
The STAT3-MYC axis promotes survival of leukemia stem cells by regulating SLC1A5 and oxidative phosphorylation
2021
·
Maria L. Amaya
, Anagha Inguva
, et al.
·
Blood
·
156
The value of allogeneic and autologous hematopoietic stem cell transplantation in prognostically favorable acute myeloid leukemia with double mutant CEBPA
2013
·
Richard F. Schlenk
, Erdogan Taskesen
, et al.
·
Blood
·
155
PDF
Current and emerging therapies for acute myeloid leukemia
2009
·
Tadeusz Robak
, Agnieszka Wierzbowska
·
Clinical Therapeutics
·
154
Safety and efficacy of gemtuzumab ozogamicin in pediatric patients with advanced CD33+ acute myeloid leukemia
2005
·
R. J. Arceci
, Jane Sande
, et al.
·
Blood
·
154
A comparative study of molecular mutations in 381 patients with myelodysplastic syndrome and in 4130 patients with acute myeloid leukemia
2007
·
U. Bacher
, T. Haferlach
, et al.
·
Haematologica
·
151
PDF
Show more works
View as search
Works count:
1,145
Citation count:
17,100
Year
Topic
Type